Aardvark Therapeutics, Inc. Common Stock AARD
AARD
Aardvark Therapeutics, Inc. Common Stock CADL
Candel Therapeutics, Inc. GALT
Galectin Therapeutics Inc. ALDX
Aldeyra Therapeutics, Inc. IMMP
Immutep Limited DRTS
Alpha Tau Medical Ltd. CTNM
Contineum Therapeutics, Inc. Class A Common Stock MREO
Mereo BioPharma Group plc ANNX
Annexon, Inc. BLRX
BioLineRx Ltd.
Aardvark Therapeutics, Inc. Common Stock CADL
Candel Therapeutics, Inc. GALT
Galectin Therapeutics Inc. ALDX
Aldeyra Therapeutics, Inc. IMMP
Immutep Limited DRTS
Alpha Tau Medical Ltd. CTNM
Contineum Therapeutics, Inc. Class A Common Stock MREO
Mereo BioPharma Group plc ANNX
Annexon, Inc. BLRX
BioLineRx Ltd.
Performance
| Periode | AARD | CADL | GALT | ALDX | IMMP | DRTS | CTNM | MREO | ANNX | BLRX |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 34.93 % | 8.43 % | 296.21 % | 96.99 % | 25.15 % | 60.23 % | 150.57 % | -20.00 % | 70.74 % | 15.53 % |
| YTD | -25.23 % | -39.93 % | 347.01 % | 0.38 % | -7.69 % | 36.45 % | -23.69 % | -41.52 % | -41.64 % | -63.60 % |
| 1Y | -25.23 % | -2.00 % | 110.04 % | -6.76 % | 6.25 % | 91.40 % | -35.27 % | -52.38 % | -57.60 % | -78.67 % |
| 3Y | -25.23 % | 184.21 % | 265.73 % | -7.42 % | 5.70 % | -16.24 % | -28.25 % | 100.00 % | -39.55 % | -88.93 % |
| 5Y | -25.23 % | -22.86 % | 100.38 % | -27.92 % | -64.83 % | -58.12 % | -28.25 % | -19.35 % | -87.14 % | -93.88 % |
| 10Y | -25.23 % | -22.86 % | 86.79 % | -18.51 % | -84.81 % | -58.12 % | -28.25 % | -69.23 % | -81.93 % | -99.56 % |
| From the beginning | -25.23 % | -22.86 % | -56.42 % | -27.22 % | -98.48 % | -58.12 % | -28.25 % | -69.23 % | -81.93 % | -99.89 % |